Details
Stereochemistry | RACEMIC |
Molecular Formula | C28H30O3 |
Molecular Weight | 414.536 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(CC)COC(=O)C1=C(C=CC=C1)C(=O)C2=CC=C(C=C2)C3=CC=CC=C3
InChI
InChIKey=TWAOKHHZKFMFMD-UHFFFAOYSA-N
InChI=1S/C28H30O3/c1-3-5-11-21(4-2)20-31-28(30)26-15-10-9-14-25(26)27(29)24-18-16-23(17-19-24)22-12-7-6-8-13-22/h6-10,12-19,21H,3-5,11,20H2,1-2H3
Molecular Formula | C28H30O3 |
Molecular Weight | 414.536 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: http://www.google.ch/patents/US4668505
Sources: http://www.google.ch/patents/US4668505
2-Ethylhexyl-4-phenyl-benzophenone carbonate (Eusolex 3573) is a component of sunscreen and possesses of ultraviolet A (UV-A) absorbing properties.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: ultraviolet A Sources: http://patents.com/us-4837019.html |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://patents.com/us-4837019.html |
Preventing | Eusolex 3573 Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.google.ch/patents/US4668505
Unknown
Route of Administration:
Topical
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:42:38 GMT 2023
by
admin
on
Fri Dec 15 15:42:38 GMT 2023
|
Record UNII |
93NOD9WBCS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C851
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID00996510
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY | |||
|
278-051-5
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY | |||
|
135606
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY | |||
|
1546353
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY | RxNorm | ||
|
75005-95-7
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY | |||
|
93NOD9WBCS
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY | |||
|
93NOD9WBCS
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY | |||
|
DB14471
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY | |||
|
C82308
Created by
admin on Fri Dec 15 15:42:38 GMT 2023 , Edited by admin on Fri Dec 15 15:42:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |